A detailed history of Stillwater Investment Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Stillwater Investment Management, LLC holds 39,201 shares of GILD stock, worth $3.68 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
39,201
Previous 38,737 1.2%
Holding current value
$3.68 Million
Previous $3.33 Million 2.2%
% of portfolio
0.87%
Previous 0.94%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 05, 2023

BUY
$77.31 - $88.08 $35,871 - $40,869
464 Added 1.2%
39,201 $3.25 Million
Q4 2022

Jan 10, 2023

BUY
$62.32 - $89.47 $19,942 - $28,630
320 Added 0.83%
38,737 $0
Q3 2022

Oct 05, 2022

BUY
$59.54 - $68.01 $25,542 - $29,176
429 Added 1.13%
38,417 $2.37 Million
Q2 2022

Jul 05, 2022

SELL
$57.72 - $65.01 $30,764 - $34,650
-533 Reduced 1.38%
37,988 $2.35 Million
Q1 2022

Apr 04, 2022

BUY
$57.92 - $72.58 $4,344 - $5,443
75 Added 0.2%
38,521 $2.29 Million
Q4 2021

Jan 04, 2022

BUY
$64.88 - $73.64 $27,314 - $31,002
421 Added 1.11%
38,446 $2.79 Million
Q3 2021

Oct 04, 2021

BUY
$67.69 - $73.03 $16,042 - $17,308
237 Added 0.63%
38,025 $2.66 Million
Q2 2021

Jul 01, 2021

SELL
$63.47 - $69.35 $9,774 - $10,679
-154 Reduced 0.41%
37,788 $2.6 Million
Q1 2021

Apr 02, 2021

BUY
$60.0 - $68.46 $58,140 - $66,337
969 Added 2.62%
37,942 $2.45 Million
Q4 2020

Jan 04, 2021

SELL
$56.65 - $64.55 $213,740 - $243,547
-3,773 Reduced 9.26%
36,973 $2.15 Million
Q3 2020

Oct 05, 2020

BUY
$62.1 - $78.08 $36,949 - $46,457
595 Added 1.48%
40,746 $2.58 Million
Q2 2020

Jul 06, 2020

BUY
$72.34 - $84.0 $33,638 - $39,060
465 Added 1.17%
40,151 $3.09 Million
Q1 2020

Apr 03, 2020

BUY
$62.63 - $80.22 $33,632 - $43,078
537 Added 1.37%
39,686 $2.97 Million
Q4 2019

Jan 03, 2020

BUY
$61.62 - $67.78 $13,679 - $15,047
222 Added 0.57%
39,149 $2.54 Million
Q3 2019

Oct 02, 2019

SELL
$62.51 - $69.0 $43,194 - $47,679
-691 Reduced 1.74%
38,927 $2.47 Million
Q2 2019

Jul 03, 2019

SELL
$61.87 - $69.38 $182,516 - $204,671
-2,950 Reduced 6.93%
39,618 $2.68 Million
Q1 2019

Apr 03, 2019

BUY
$62.53 - $70.05 $43,520 - $48,754
696 Added 1.66%
42,568 $2.77 Million
Q4 2018

Jan 04, 2019

SELL
$60.54 - $79.0 $109,637 - $143,069
-1,811 Reduced 4.15%
41,872 $2.62 Million
Q3 2018

Oct 03, 2018

BUY
$71.28 - $78.92 $9,408 - $10,417
132 Added 0.3%
43,683 $3.37 Million
Q2 2018

Jul 05, 2018

BUY
$64.88 - $75.68 $16,868 - $19,676
260 Added 0.6%
43,551 $3.09 Million
Q1 2018

Apr 04, 2018

BUY
$72.84 - $88.8 $188,291 - $229,548
2,585 Added 6.35%
43,291 $3.26 Million
Q4 2017

Jan 04, 2018

BUY
$71.15 - $83.52 $238,708 - $280,209
3,355 Added 8.98%
40,706 $2.92 Million
Q3 2017

Oct 04, 2017

BUY
$72.11 - $85.47 $2.69 Million - $3.19 Million
37,351
37,351 $3.03 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Stillwater Investment Management, LLC Portfolio

Follow Stillwater Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stillwater Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stillwater Investment Management, LLC with notifications on news.